Stay updated with breaking news from Stanley Qi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA recently approved Casgevy, a gene-editing medical treatment which uses CRISPR/Cas9 technology to treat sickle cell disease. Casgevy, which two Stanford faculty members contributed to via drug development and FDA approval, is the first gene-editing medical treatment to recieve FDA approval.
A system that edits RNA rather than DNA can give new life to exhausted CAR T cells. A system that edits RNA rather than DNA can give new life to exhausted CAR T cells.
SAN FRANCISCO, Jan. 12, 2024 /PRNewswire/ -- Every January, the global medical health and financial investment sectors turn their focus to San Francisco. The J.P. Morgan Healthcare Conference has...
SAN FRANCISCO, Jan. 12, 2024 /PRNewswire/ -- Every January, the global medical health and financial investment sectors turn their focus to San Francisco.
Using microfluidics, the lab seeks to accelerate research on T-cell interactions that would help patients' immune systems treat diseases like cancer.